Three independent discounted-cash-flow-style models value Abbott Laboratories every trading day. 0 of 3 currently price ABT above its market price.
| Free Cash Flow model | $65.26 |
| Excess Profit model | $49.65 |
| Residual Earnings model | $70.20 |
| Dividend Discount model | $92.77 |
| Piotroski F-Score | 6 / 9 |
| Return on invested capital | +9.8% |
| Net debt / EBITDA | 0.5× |
| Gross margin | +56.4% |
| Revenue CAGR | +0.5% |
| Cash conversion | 1.5× |
| Dividend yield | +3.2% |
| Buyback yield | -0.1% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open ABT in StockKitty